OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
FTPP, prohibitin-targeting peptidomimetic. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|
A vascular-targeting peptidomimetic that ablates white adipose vasculature. Research studies showed weight loss alongside dose-dependent renal toxicity. Development did not proceed. This compound has a genuine documented harm signal.
Buy Adipotidethis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
An estrogen-related receptor pan-agonist described as an exercise mimetic in preclinical models. Not a peptide, no human data of a…
An AMPK-activating nucleoside studied for ischaemia protection and as an exercise mimetic in preclinical research. Requires very l…
Every compound compared in one table: dose range, how often, half-life and evidence tier.